Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics tags : Money save search
BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule - April 11, 2024
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
BCLI A | $0.5339 1.7% 1.67% 190K
|
Health Technology
|
| O: -0.17%
H: 13.56%
C: -2.19%
nasdaq cell therapeutics market
Sage Therapeutics to Report First Quarter 2024 Financial Results on Thursday, April 25, 2024
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
SAGE | $14.0 8.11% 7.5% 2.3M
|
Health Technology
|
| O: 2.37%
H: 0.9%
C: -0.54%
first report therapeutics financial results
Contineum Therapeutics Announces Pricing of Initial Public Offering - April 05, 2024
Published: 2024-04-05 (Crawled : 09:00) - biospace.com/
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -2.11%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
offering therapeutics
Capstan Therapeutics Announces $175M Oversubscribed Series B Financing
Published: 2024-03-20 (Crawled : 13:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.65%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.35%
H: 0.4%
C: 0.36%
series therapeutics
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
Published: 2024-03-20 (Crawled : 11:00) - biospace.com/
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -5.51%
H: 1.33%
C: 1.2%
AUTL | $4.23 -5.58% -5.91% 2.7M
|
Health Technology
|
| O: 1.45%
H: 5.33%
C: 4.13%
year update financial results
Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of Equity
Published: 2024-03-12 (Crawled : 12:30) - biospace.com/
RGLS | $2.23 -1.33% -1.35% 92K
|
Health Technology
|
| O: 68.84%
H: 62.66%
C: 1.29%
million therapeutics
Adaptimmune Reports Q4/Full Year 2023 Financial Results and Business Updates
Published: 2024-03-06 (Crawled : 13:30) - biospace.com/
ADAP | $1.085 -4.83% -5.07% 780K
|
Health Technology
|
| O: 8.9%
H: 10.06%
C: 7.55%
business year financial results
Akero Therapeutics Announces Pricing of Public Offering of Common Stock - March 06, 2024
Published: 2024-03-06 (Crawled : 12:00) - biospace.com/
MS | News 0 d | $93.85 0.1% 0.0% 4.8M
|
Finance
|
| O: -2.65%
H: 1.36%
C: -1.28%
AKRO | $20.23 -3.67% -3.81% 580K
|
Health Technology
|
| O: 2.23%
H: 3.85%
C: -3.85%
offering therapeutics
Janux Therapeutics Announces Pricing of $296.5 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
Published: 2024-02-29 (Crawled : 10:00) - biospace.com/
JANX | $48.14 -3.29% -3.41% 580K
|
Professional, Scientific, and T...
|
| O: 11.86%
H: 5.3%
C: -7.18%
million offering therapeutics
Adaptimmune to Report Q4 and Full Year 2023 Financial and Business Updates on Wednesday, March 6, 2024
Published: 2024-02-22 (Crawled : 15:30) - biospace.com/
ADAP | $1.085 -4.83% -5.07% 780K
|
Health Technology
|
| O: 2.0%
H: 7.06%
C: -9.8%
report business year financial
NextPoint Therapeutics Announces Closing of Series B Financing Extension Led by Catalio Capital Management
Published: 2024-02-14 (Crawled : 13:30) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -2.71%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
management series extension therapeutics
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2023 Financial Results Before the Market Opens on Wednesday, February 21, 2024
Published: 2024-02-14 (Crawled : 12:00) - biospace.com/
UTHR | $237.06 1.11% 1.09% 610K
|
Health Technology
|
| O: -0.29%
H: 0.72%
C: 0.61%
report year corporation therapeutics financial results market
Areteia Therapeutics Announces Additional $75MM in Series A Financing for Oral Dexpramipexole in Eosinophilic Asthma
Published: 2024-02-13 (Crawled : 13:30) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
series therapeutics
Precision BioSciences Receives Initial $7.5 Million Cash Payment and Equity Investment from TG Therapeutics for Azel-Cel in Treatment of Autoimmune Diseases
Published: 2024-02-12 (Crawled : 13:30) - biospace.com/
TGTX | $13.99 -1.83% -1.86% 2.7M
|
Health Technology
|
| O: 1.15%
H: 1.88%
C: 1.81%
DTIL | $9.81 -4.11% -4.28% 34K
|
Health Technology
|
| O: 1.56%
H: 3.51%
C: -3.82%
precision million payment treatment therapeutics
4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock - February 07, 2024
Published: 2024-02-07 (Crawled : 12:00) - biospace.com/
FDMT M | $24.255 -2.24% -2.29% 290K
|
Health Technology
|
| O: 0.42%
H: 1.35%
C: -15.32%
offering therapeutics molecular
Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering Medicines
Published: 2024-01-05 (Crawled : 17:00) - biospace.com/
OMGA | $2.335 -0.21% -0.21% 200K
|
|
| O: 1.41%
H: 0.37%
C: -18.55%
SANA | $8.58 6.06% 5.71% 1.2M
|
|
| O: 2.04%
H: 10.8%
C: 2.0%
MCRB | $0.7295 -4.01% -4.18% 5.8M
|
Health Technology
|
| O: 0.71%
H: 2.84%
C: -0.71%
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: -0.82%
H: 7.46%
C: 3.11%
FHTX | $5.21 0.97% 0.96% 110K
|
Health Technology
|
| O: -1.79%
H: 7.65%
C: 2.55%
DNLI | $15.55 -3.48% -3.6% 940K
|
Health Technology
|
| O: -2.47%
H: 0.66%
C: -2.18%
update fibrosis research
Voyager Therapeutics Announces Pricing of Public Offering - Jan 05, 2024
Published: 2024-01-05 (Crawled : 09:00) - biospace.com/
VYGR | News | $7.57 -1.05% -1.06% 310K
|
Health Technology
|
| O: -17.62%
H: 0.9%
C: -0.9%
offering therapeutics
Adaptimmune Projects Sarcoma Franchise to Deliver US Peak Year Sales up to $400 Million - Presentation at JP Morgan Healthcare Conference
Published: 2024-01-04 (Crawled : 15:00) - biospace.com/
ADAP | $1.085 -4.83% -5.07% 780K
|
Health Technology
|
| O: 5.34%
H: 11.7%
C: 6.71%
sales conference year presentation million
Lyndra Therapeutics Raises $101 Million in Series E Funding
Published: 2023-12-21 (Crawled : 15:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.29%
H: 0.76%
C: 0.14%
million series therapeutics funding
SpringWorks Therapeutics Announces Pricing of Upsized Public Offering of Common Stock - December 05, 2023
Published: 2023-12-05 (Crawled : 07:00) - biospace.com/
SWTX | $43.37 -1.43% -1.45% 470K
|
Health Technology
|
| O: -8.4%
H: 3.28%
C: -0.21%
offering therapeutics
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.